Concerta
Concerta 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为ADHD。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
11 项
已进入 III/IV 期
11 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- Stéphanie Baggio
- Nantes University Hospital
- University of Haifa
- Matthew J O'Brien, PhD, BCBA-D
- Lei Lei, MD
- Duke University
- VA Office of Research and Development
- Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
法国、Israel、美国、中国、加拿大、中国台湾、瑞典、比利时、荷兰、意大利、瑞士
正在招募患者的 Concerta 研究
MEthylphenidate in ADHD - Addiction(s) Comorbidity: Value of Adding a Cognitive Remediation Program to Improve Short- and Medium-term Therapeutic Response
不适用招募中法国NCT06906328The Efficacy of a Pharmacological Treatment (Reboxetine Plus Ritalin) Versus Dog-Assisted Therapy in PTSD
II 期招募中IsraelNCT07771530Stimulant Effects on Disruptive Behavior
IV 期招募中美国NCT03420339Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.
不适用招募中中国NCT06369714Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
不适用招募中美国加拿大NCT03511118Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
IV 期招募中美国NCT04419272Medication Treatment of ADHD in Pediatric Epilepsy
IV 期招募中美国NCT07594652The Role of Brain Dopamine in Chronic Pain
II 期招募中美国NCT05285683Attention Deficit Hyperactivity Disorder
不适用招募中法国NCT06232226The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome
IV 期招募中IsraelNCT00768820Pharmacogenomics of Stimulant Treatment Response
不适用招募中加拿大NCT06221358Multimodal Biomarkers Predicting Medication-Induced Adverse Effects in Children With ADHD
不适用招募中中国台湾NCT07900451An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
IV 期招募中美国NCT06577779Evaluation of the Relationship Between Medication, Eye Movements, and Autonomic Nervous System (ANS) Functions in Children and Adolescents With ADHD
不适用招募中瑞典NCT07634809Evaluation of Foquest in Adults 65 Years and Older With ADHD
IV 期招募中加拿大NCT07710014The Role of the Brain in Mental and Physical Fatigue
III 期招募中比利时NCT05880342Treating Young Children With Attention Deficit Hyperactivity Disorder
IV 期招募中美国NCT07300956Methylphenidate in KBG Syndrome: N-of-1 Series
IV 期招募中荷兰NCT06465641AWARE: Management of ADHD in Autism Spectrum Disorder
IV 期招募中美国加拿大NCT05916339Assessing Real Life Effectiveness of Treatment in Neurodevelopmental Disorders
不适用招募中意大利NCT07273695Benefits of ADHD Treatment in Detained People
III 期招募中瑞士NCT05842330Efficacy of Reboxetine and Methylphenidate Treatment on Attentional, Sensory and Emotional Dysregulation in Adults With PTSD
II 期招募中IsraelNCT05133804Oxygen Toxicity: Mechanisms in Humans
不适用招募中美国NCT05761756Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
I 期招募中美国NCT07226219
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。